Gelfoam Compressed Sponge
- Generic Name: absorbable gelatin compressed sponge, usp
- Brand Name: Gelfoam Compressed Sponge
Gelfoam Compressed Sponge (Absorbable Gelatin Compressed Sponge, USP) side effects drug center
Gelfoam Compressed Sponge Side Effects Center
Gelfoam Compressed Sponge (absorbable gelatin compressed sponge) is a medical device intended for application to bleeding surfaces is indicated in surgical procedures as a hemostatic device, when control of capillary, venous, and arteriolar bleeding by pressure, ligature, and other conventional procedures is either ineffective or impractical. Although not necessary, Gelfoam Compressed Sponge can be used either with or without thrombin to obtain hemostasis. Common side effects of Gelfoam Compressed Sponge include:
- fever
- infection
- abscess formation
- foreign body reactions
- “encapsulation” of fluid
- blood clots
The minimum amount of Gelfoam Compressed Sponge of appropriate size and shape should be applied dry or wet to the bleeding site and held firmly in place until hemostasis is observed. Gelfoam Compressed Sponge may interact with other drugs or topical agents. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or breastfeeding before receiving Gelfoam Compressed Sponge.
Our Gelfoam Compressed Sponge (absorbable gelatin compressed sponge) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
Gelfoam Compressed Sponge Professional Information
SIDE EFFECTS
There have been reports of fever associated with the use of GELFOAM, without demonstrable infection. GELFOAM Sterile Compressed Sponge may form a nidus of infection and abscess formation1, and has been reported to potentiate bacterial growth. Giant-cell granuloma has been reported at the implantation site of absorbable gelatin product in the brain2, and compression of the brain and spinal cord resulting from an accumulation of sterile fluid3 has been reported following use of absorbable gelatin sponge in closed space.
Foreign body reactions, “encapsulation” of fluid and hematoma have also been reported. When GELFOAM was used in laminectomy operations, multiple neurologic events were reported, including but not limited to cauda equina syndrome, spinal stenosis, meningitis, arachnoiditis, headaches, paresthesias, pain, bladder and bowel dysfunction, and impotence.
Excessive fibrosis and prolonged fixation of a tendon have been reported when absorbable gelatin products were used in severed tendon repair.
Toxic shock syndrome has been reported in association with the use of GELFOAM in nasal surgery.
Fever, failure of absorption, and hearing loss have been reported in association with the use of GELFOAM during tympanoplasty.
Adverse Reactions Reported From Unapproved Use
GELFOAM is not recommended for use other than as an adjunct for hemostasis. While some adverse medical events following the unapproved use of GELFOAM have been reported (see ADVERSE REACTIONS), other hazards associated with such use may not have been reported.
When GELFOAM has been used during intravascular catheterization for the purpose of producing vessel occlusion, the following adverse events have been reported; fever, duodenal and pancreatic infarct, embolization of lower extremity vessels, pulmonary embolization, splenic abscess, necrosis of specific anatomic areas, asterixis, and death. These adverse medical events have been associated with the use of GELFOAM for repair of dural defects encountered during laminectomy and craniotomy operations: fever, infection, leg paresthesias, neck and back pain, bladder and bowel incontinence, cauda equina syndrome, neurogenic bladder, impotence, and paresis.
Read the entire FDA prescribing information for Gelfoam Compressed Sponge (Absorbable Gelatin Compressed Sponge, USP)
&Copy; Gelfoam Compressed Sponge Patient Information is supplied by Cerner Multum, Inc. and Gelfoam Compressed Sponge Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.